Showing results (181-190 of 205) with videos related to

Sort By:
Pageof 21
JCI Insight|July 27, 2018
Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomesJasmine C Wong, Victoria Bryant, Tamara Lamprecht, et al.
The Lancet. Oncology|April 17, 2016
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trialJeffrey H Lipton, Charles Chuah, Agnès Guerci-Bresler, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2005
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinasesTodd A Carter, Lisa M Wodicka, Neil P Shah, et al.
Nature Chemical Biology|April 30, 2021
ABHD17 regulation of plasma membrane palmitoylation and N-Ras-dependent cancer growthJarrett R Remsberg, Radu M Suciu, Noemi A Zambetti, et al.
Nature Medicine|February 14, 2017
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemiaNina Fenouille, Christopher F Bassil, Issam Ben-Sahra, et al.
Cancer Cell|November 6, 2018
Widespread Selection for Oncogenic Mutant Allele Imbalance in CancerCraig M Bielski, Mark T A Donoghue, Mayur Gadiya, et al.
JCI Insight|September 29, 2020
KrasP34R and KrasT58I mutations induce distinct RASopathy phenotypes in miceJasmine C Wong, Pedro A Perez-Mancera, Tannie Q Huang, et al.
Pageof 21